DexCom (DXCM) Appoints Jon Coleman as CCO
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/26/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Dexcom Appoints Jon Coleman as Chief Commercial Officer
March 25, 2025 4:05 PM EDTSAN DIEGO--(BUSINESS WIRE)-- DexCom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing, today announced the appointment of Jon Coleman as chief commercial officer. In this role, Mr. Coleman will assume responsibility for Dexcoms global commercial organization, including global sales, marketing and customer experience.
Mr. Coleman joins Dexcom with more than 30 years of global... More



